Manipal Health Enterprises Ltd

Thakral Corporation Ltd, through its Indian subsidiary TIL Investments Pvt Ltd, has entered into a long-term land lease agreement with Manipal Health Enterprises Limited for approximately 3.5 acres of land in Gurugram, Delhi NCR. Manipal Hospitals will develop and operate a multi-speciality hospital on this site, with the first phase expected to have up to 500 beds. The lease is for an initial period of approximately 30 years. This expansion is part of Manipal Hospitals' strategy to strengthen its presence in the Delhi NCR region and address growing healthcare demands. Thakral Corporation views this as an opportunity to participate in India's healthcare sector growth and enter healthcare-focused real estate.

Manipal Health Enterprises Ltd has executed a Lease Deed with TIL Investments Private Limited for a parcel of land in Gurugram, Haryana. The lease, valid for 29 years and 11 months, is intended for the construction, operation, management, and maintenance of a new hospital. The agreement does not involve any special rights beyond customary lease terms and is not considered a related party transaction.

Manipal Health Enterprises Ltd has announced that its Board of Directors will convene on November 13, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Financial Results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026. The company will also present the Limited Review Report from its Statutory Auditors. These financial results will be made available on the company's website.

MEMG International India Pvt Ltd, a promoter group entity of Manipal Health Enterprises Limited, has disclosed the creation of a pledge over 1,44,92,951 equity shares, representing 1.79% of the total share capital. This pledge was executed on October 24, 2026, in favor of Vistra ITCL (India) Limited, acting as the debenture trustee. This action is related to non-convertible debentures (NCDs) aggregating up to INR 500,00,00,000 issued under a debenture trust deed dated August 25, 2026. Certain covenants in the nature of encumbrance were already subsisting on these shares, and the new pledge does not involve additional shares.

Manipal Health Enterprises Limited has disclosed that MEMG International India Private Limited, an entity in the promoter group, has created a pledge over 1,44,92,951 equity shares of the company. This pledge, executed on October 24, 2026, is in favor of Vistra ITCL (India) Limited, acting as the debenture trustee for non-convertible debentures (NCDs) aggregating up to INR 500,00,00,000. Certain covenants in the nature of encumbrance were already subsisting on these shares, and this pledge does not involve additional shares.

Manipal Health Enterprises Ltd announced that its subsidiary, Manipal Hospitals Eastern India Private Limited, has received orders from GST authorities. The orders, received on August 14, 2026, and September 11, 2026, pertain to demands of ₹4,22,95,004 (₹4.23 Crore) and ₹3,77,52,668 (₹3.78 Crore) respectively, along with penalties and interest. These orders are related to issues in input tax credit and outward supplies for FY 2019-20 and FY 2021-22. The company stated there is no material impact on its financial or operational activities and that it intends to appeal these orders.

MEMG International India Private Limited, an entity within the promoter group of Manipal Health Enterprises Limited, has disclosed the release of pledges on certain shares of the company. Specifically, a pledge of 72,50,000 shares in favor of Vistra ITCL (India) Limited (as debenture trustee) securing debentures issued by Claypond Capital Partners Private Limited has been released. Additionally, a pledge of 72,42,951 shares in favor of 360 One Prime Limited (as lender) securing a facility availed by Manipal Education and Medical Group India Private Limited has also been released. While these specific pledges are resolved, certain other covenants in the nature of encumbrance remain subsisting.

Manipal Health Enterprises Limited held its 16th Annual General Meeting (AGM) on September 29, 2026, via Video Conferencing. The meeting, conducted in accordance with the Companies Act, 2013 and SEBI regulations, saw the participation of Directors, Key Managerial Personnel, and Members. The Chairman's address highlighted the company's performance for the financial year 2025-26, noting a significant increase in revenue from operations to ₹10,336 crores, a 25.4% rise from the previous year. Operating EBITDA reached ₹2,644 crores with an EBITDA margin of 25.6%, and profit for the year stood at ₹917 crores. The company also reported volume-led growth with an increase in inpatient volumes from 4.39 Lakhs to 5.27 Lakhs.

Manipal Health Enterprises Ltd has announced the closure of its trading window for dealing in securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from October 1, 2026, and will reopen 48 hours after the announcement of the financial results for the quarter and half-year ended September 30, 2026. All designated persons and insiders are advised not to trade in the company's shares during this period. The company will also post this information on its website.

Manipal Health Enterprises Limited (Manipal Hospitals) has fully redeemed its outstanding listed non-convertible debentures (NCDs) worth ₹5,310 crore. The redemption utilized a portion of the proceeds from its Initial Public Offering (IPO). This move is a significant step in the company's post-listing financial strategy, aimed at strengthening its balance sheet, reducing interest burden, and improving financial leverage. The company also reported strong Q1 FY27 performance with revenue up 38.1% YoY to ₹3,091 crore and EBITDA up 26.4% to ₹749 crore. This proactive debt management is expected to provide greater financial flexibility for future growth and investment priorities.